 | Up a level |
Bihl, Florian; Bruggmann, Philip; Castro Batänjer, Erika; Dufour, Jean-François; Lavanchy, Daniel; Müllhaupt, Beat; Negro, Francesco; Razavi, Homie; Scheidegger, Claude; Semela, David; Semmo, Nasser; Blach, Sarah (2022). HCV disease burden and population segments in Switzerland. Liver international, 42(2), pp. 330-339. Wiley 10.1111/liv.15111
Bruggmann, Philip; Blach, Sarah; Deltenre, Pierre; Fehr, Jan; Kouyos, Roger; Lavanchy, Daniel; Müllhaupt, Beat; Rauch, Andri; Razavi, Homie; Schmid, Patrick; Semela, David; Stoeckle, Marcel; Negro, Franco (2017). Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss medical weekly, 147(w14543), w14543. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14543
Fretz, Rainer; Negro, Francesco; Bruggmann, Philip; Lavanchy, Daniel; De Gottardi, Andrea; Pache, Isabelle; Masserey Spicher, Virginie; Cerny, Andreas (2013). Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss medical weekly, 143, w13793. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13793
